Exelixis & Aerie Have Good News Exelixis’ Good News about Cabometyx Takeda Pharmaceuticals applied to the …

Zolgensma Findings The FDA submission of the gene therapy product Zolgensma was based on positive findings …

Gilead and insitro Collaborate to Discover and Develop Novel Therapies for NASH using ISH Gilead Sciences …

Amgen and UDB Granted FDA Approval of Evenity™ Amgen (AMGN) and UCB Pharmaceuticals (

The Amgen/Novartis Story In May 2018 Amgen (AMGN) & Novartis (

Sangamo’s Stock Price Soars Sangamo Therapeutics’ (SGMO) stock soared more than 52% in pre-market trading following …

Following Seattle Genetics' (SGEN) and Astellas Pharma's announcement of positive results, from pivotal trial of the conjugated monoclonal antibody …

While waiting for Mueller’s report we stopped speculating on the stocks in what we saw as …

Biogen’s (BIIB) decision to discontinue the global Phase 3 trials, ENGAGE and EMERGE which is designed …

The Week in Review #39 During the Departed Week Three Prohost Portfolio Picks Hit Their 52-Week …